Search results
Results from the WOW.Com Content Network
The first left ventricular assist device (LVAD) system was created by Domingo Liotta at Baylor College of Medicine in Houston in 1962. The first LVAD was implanted in 1963 by Liotta and E. Stanley Crawford. The first successful implantation of an LVAD was completed in 1966 by Liotta along with Dr. Michael E. DeBakey.
Thoratec's third-generation HeartMate LVAD is the HeartMate 3, [48] [49] designed to lower adverse event rates through improved hemocompatibility, and to increase ease of surgical placement through new design and compact size. [50] [51] It began undergoing clinical trials in the U.S. and internationally in mid 2014. [48] [49] [50] [52] [53]
In 1994, he instigated research on the HeartWare LVAD and described the first long-term clinical use of a LVAD. This person was the first to make hospital discharge with a LVAD. [11] His most significant contribution was the development of the nonpulsatile implantable LVADs, the Jarvik, HeartMate II and HeartWare. [6]
Jack Greene Copeland (born 1942) is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart (heterotopic heart transplant) in ...
Endoscopic third ventriculostomy (ETV) is a surgical procedure for treatment of hydrocephalus in which an opening is created in the floor of the third ventricle using an endoscope placed within the ventricular system through a burr hole. This allows the cerebrospinal fluid to flow directly to the basal cisterns, bypassing the obstruction.
Pituitary adenomas are tumors that occur in the pituitary gland. Most pituitary tumors are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. [1] Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms, with an estimated prevalence rate in the general population of approximately 17%. [1] [2]
A ventricular outflow tract obstruction means there is a limitation in the blood flow out of either the right or left ventricles of the heart, depending on where the obstruction is. This can lead to cardiac hypertrophy , dilatation of the heart, and ultimately heart failure in some cases. [ 1 ]
Hypophysectomy is the surgical removal of the hypophysis (pituitary gland). It is most commonly performed to treat tumors, especially craniopharyngioma tumors. [1] Sometimes it is used to treat Cushing's syndrome due to pituitary adenoma [2] or Simmond's disease [3] It is also applied in neurosciences (in experiments with lab animals) to understand the functioning of hypophysis.